tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with dermorphin in 3 studies
| Studies (tyrosyl-arginyl-phenylalanyl-lysinamide) | Trials (tyrosyl-arginyl-phenylalanyl-lysinamide) | Recent Studies (post-2010) (tyrosyl-arginyl-phenylalanyl-lysinamide) | Studies (dermorphin) | Trials (dermorphin) | Recent Studies (post-2010) (dermorphin) |
|---|---|---|---|---|---|
| 74 | 0 | 17 | 401 | 2 | 39 |
| Protein | Taxonomy | tyrosyl-arginyl-phenylalanyl-lysinamide (IC50) | dermorphin (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0389 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0043 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.0018 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.2492 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.0086 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Imam, MZ; Kong, D; Kuo, A; Smith, MT; Williams, CM | 1 |
| Neilan, CL; Nguyen, TM; Pasternak, GW; Schiller, PW | 1 |
| Fay, S; Guan, F; Li, X; Robinson, MA; You, Y | 1 |
3 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and dermorphin
| Article | Year |
|---|---|
Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources.
Topics: Analgesics, Opioid; Animals; Biological Products; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Discovery; Humans; Ligands; Pain; Peptides; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2022 |
Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, a highly potent and selective mu-opioid peptide.
Topics: Analgesics; Animals; Drug Tolerance; Humans; Mice; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Oligodeoxyribonucleotides, Antisense; Oligopeptides; Opioid Peptides; Pain Measurement; Receptors, Opioid, mu; Time Factors | 2001 |
Identification of ex vivo catabolites of peptides with doping potential in equine plasma by HILIC-HRMS.
Topics: Amino Acid Sequence; Animals; Biotransformation; Chromatography, High Pressure Liquid; Computer Simulation; Doping in Sports; Growth Hormone-Releasing Hormone; Horses; Magnetic Resonance Spectroscopy; Mass Spectrometry; Oligopeptides; Opioid Peptides; Peptides; Solid Phase Extraction; Substance Abuse Detection | 2020 |